NCT06940258

Brief Summary

Traumatic brain injury is a leading cause of death and disability in trauma patients. As the primary injury cannot be reversed; management strategies must focus on preventing secondary injury by avoiding hypotension and hypoxia besides, maintaining appropriate cerebral perfusion pressure, which is a surrogate for cerebral blood flow.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started May 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
May 2025Jul 2026

First Submitted

Initial submission to the registry

April 15, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

April 29, 2025

Status Verified

April 1, 2025

Enrollment Period

12 months

First QC Date

April 15, 2025

Last Update Submit

April 25, 2025

Conditions

Keywords

caval aorta indextraumatic brain injury

Outcome Measures

Primary Outcomes (1)

  • fluid balance

    the difference between fluid input and fluid loss

    after 96 hours from the admission

Secondary Outcomes (6)

  • Urine output

    Daily for 7 weeks

  • Central Venous Pressure (CVP) measurements

    Daily every 6 hours for 7 days

  • Frequency and duration of hypotension

    within first 7 days

  • Glasgow Coma Scale

    daily within first 7 days

  • Central capillary refill

    Daily for 7 days

  • +1 more secondary outcomes

Study Arms (2)

Control group

OTHER
Other: control group

ultrasound-guided caval-aorta index group

EXPERIMENTAL
Procedure: ultrasound measurement of caval aorta index

Interventions

ultrasound measurement of caval aorta index

ultrasound-guided caval-aorta index group

fixed fluid prescription

Control group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Traumatic brain injury diagnosed by computed tomography scan Glasgow coma score ≥ 4

You may not qualify if:

  • Inability to get consent. Pregnant and lactating women Traumatic subarachnoid hemorrhage Spinal cord injury Increased intra-abdominal pressure Abdominal aortic aneurysm Inferior vena cava (IVC) thrombus Portal hypertension Acute corpulmonale Congestive heart failure chronic hemodialysis Surgical intervention other than neurological one within the first 7 days Mechanical ventilation need during first 7 days Cardiac arrest during the first 7 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Maha Ahmed Abozeid, Assistant Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
A vascular US expert will read the number contained in computer generated randomization software and determine group assignments. Daily; he will be responsible on prescribing of the required fluid.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: After enrollment, patients will be randomly allocated using block into two groups of 46 patients in each group; ultrasound-guided fluid management (US group) or standard care (C group)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesia and Surgical Intensive Care

Study Record Dates

First Submitted

April 15, 2025

First Posted

April 23, 2025

Study Start

May 1, 2025

Primary Completion

April 30, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

April 29, 2025

Record last verified: 2025-04